Heart transplant warning: could a simple virus test spot rejection early?
NCT ID NCT05064462
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 60 heart transplant patients for one year to see if levels of a harmless virus called TTV in the blood are linked to infections or organ rejection. Researchers took monthly blood samples alongside routine care. The goal is to find a new way to monitor transplant health without extra procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors monitor heart transplant patients more closely and catch problems like infection or rejection earlier.
What could go wrong
This is an observational study, not a treatment trial. It only looks for a link between TTV levels and outcomes, so it cannot prove cause and effect. The results may not apply to all transplant patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU de Rennes
Rennes, 35033, France
-
Hôpital européen Georges Pompidou
Paris, 75015, France